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A B S T R A C T
Since its ﬁrst release in 2008, Norine remains the unique resource completely devoted to nonribosomal
peptides (NRPs). They are very attractive microbial secondary metabolites, displaying a remarkable di-
versity of structure and functions. Norine (http://bioinfo.liﬂ.fr/NRP) includes a database now containing
more than 1160 annotated peptides and user-friendly interfaces enabling the querying of the database,
through the annotations or the structure of the peptides. Dedicated tools are associated for structural
comparison of the compounds and prediction of their biological activities. In this paper, we start by de-
scribing the knowledgebase and the dedicated tools. We then present some user cases to show how useful
Norine is for the discovery of novel nonribosomal peptides.
© 2016 The authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
1. Introduction
Nonribosomal peptides (NRPs) are attractive natural compounds
because of their numerous biological activities potentially exploited by
industries in diverse areas such as phytosanitary sector, cosmetics or
health. They are produced by microorganisms (including bacteria
and fungi) through specialized biosynthetic pathways. NRPs are
biosynthesized by enzymaticmodular complexes calledNonRibosomal
Peptide Synthetases (NRPSs)working asmultidomain assembly lines.1
Themode of synthesis leads to the production of compounds display-
ing abroad rangeof structures. Indeed, if someof them look like classical
peptides because they are linear, most of them are more complex, in-
cluding one ormore cycles and branches.Moreover, those peptides are
composed of monomers that are not limited to the 20 proteinogenic
amino acids. Up to now, we have identiﬁed more than 530 building
blocks composing the different NRPs. The structural biodiversity is also
due to themonomermodiﬁcations occurringduring the synthesismade
by the NRPSs themselves or performed post synthesis by accessory
enzymes (also named tailoring or decorating enzymes). Famous ex-
amples for NRPs are the antibiotics penicillin,2 bacitracin and
vancomycin,3 or the immunosuppressor cyclosporine.4 In addition, some
NRPs show antitumor activity such as Dactinomycin.5 A current wor-
rying public health issue is to ﬁnd and develop newdrugs to overcome
multi-resistant pathogens. Therefore, it is important to develop bioin-
formatics tools for secondarymetabolite discovery, such as antiSMASH6
and tools especially dedicated to NRPSs and NRPs, such as Florine,7
NaPDos,8 and Norine.9,10 The development of Norine was ﬁrst moti-
vated by the availability of computational tools allowing structure
comparison of all NRPs,11 in spite of their complexity. For this purpose,
we needed a database gathering all known NRPs, annotated accord-
ing to their monomeric structure (i.e. monomer composition and 2D
topology). Until now, the Norine team screened the literature to enter
new peptides and annotated themmanually. To get a more complete
database,wehave recently opened it to crowdsourcing through an easy-
to-use web-based application.10 Moreover, a semi-automatic process
to extract data from external sources is currently under development.
2. The Norine database
2.1. Description and querying
Norine is a platform that includes the unique database dedi-
cated to NRPs, associated with computational tools for their analysis.
It has gained an international recognition thanks to high quality and
manually curated annotations. Containing about 700 annotated NRPs
for its ﬁrst release in 2008, Norine database now contains more than
1160 NRPs that are clustered into 214 families, and composed of
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at least 530 distinct monomers. Among the peptides, 73.5% are
tagged with the “curated” status, which means that their
nonribosomal origin is supported experimentally (for example due
to identiﬁed NRPS) while 26.5% are annotated with “putative” status
due to only presumed nonribosomal origin (often based on struc-
tural features). Two thirds of the peptides are cyclic or partially cyclic
or contain at least one cycle. The sizes of the peptides range from
2 to 26 monomers, if polytheonamide is excluded, which was de-
scribed as being the biggest NRP with 49 monomers for a long time
but recently was identiﬁed to be an RiPP (Ribosomally synthe-
sized and post-translationally modiﬁed peptide).12 Thus, in the near
future, a third category will be created to tag all deprecated pep-
tides when the hypothetical NRPS origin is ﬁnally excluded.
Each peptide page includes a comprehensive description of the
peptide with the name, activities and structural atomic and mo-
nomeric details. The monomeric structure can be automatically
obtained through the integrated smiles2monomers tool (s2m) when
SMILES are available.13 When identiﬁed, links to UniProt (for syn-
thetases), PDB and PubChem (for structural data on the peptides)
are provided. Moreover, a direct link to the NRPS gene clusters an-
notated in MIBiG14 will be added soon.
Norine is queried from all over the world by biologists and bio-
chemists to further analyze the nonribosomal peptides they study.
For example, Desriac et al.15 queried Norine to predict the antibac-
terial activity of a putative NRP produced by Pseudoalteromonas, while
Bills et al.16 used Norine to investigate the structural differences
between bacterial and fungal NRPs. Indeed, for this purpose, the
Norine platform provides visualization and editing applets for mo-
nomeric structure as well as tools to comparemonomeric structures.
Currently, Norine can be queried either by annotations (through
“general search” tab) or by structural information (through “struc-
ture search” tab) of the peptides.
2.1.1. General search
Norine provides a basic interface that enables to query the da-
tabase and search for peptides by combining multiple criteria, such
as the name of the peptide, the Norine ID, the biological activities,
the structure type, the producing organism, or the title or authors
of references associated to the NRP. The main advantage of this in-
terface is that it allows users to extract data and get statistics
according to different criteria. For example, one can query for all
siderophores produced by “any bacteria” (check “siderophore” in
the “activity” ﬁeld and enter “bacteria” in the “organism search”
ﬁeld), or all peptides with a linear structure, or simply search for
all NRPs produced by the genus “Pseudomonas” (enter “pseudomo-
nas” in the “organism search” ﬁeld) (see the results in Fig. 1). The
ﬁrst output is a list of all the peptides corresponding to the crite-
ria selected, classiﬁed by families. A click on a peptide name directs
to the peptide page containing all details on the compound. More-
over, a click on the pie chart icon located above the list of results
provides graphical output (Fig. 1). Pie charts and diagrams enable
to ﬁlter the obtained results in order to reﬁne them, by clicking on
a slice, for example by structure type or monomers size.
Fig. 1. Graphical output provided with Pseudomonas query in “organism search” form. (A) Pie charts representing the percentages of the nonribosomal peptides produced
by Pseudomonas, according to their status, their class, their structure types and their activities. (B) Histogram representing size distribution of the peptides produced by
Pseudomonas. For lipopeptides, the fatty acid is considered as one monomer.
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2.1.2. Structure search
In addition to search through annotations, Norine proposes ef-
ﬁcient structure search tools based on different algorithms:
monomeric composition ﬁngerprint (MCFP),17 structure-based search
for pattern comparison and similarity-based search.11,18 These enable
to ﬁnd peptides containing a given list of monomers or a given 2D-
pattern for structural comparisons. In Norine, a speciﬁc syntax is
used (the NOR format) to describe the two-dimension graph of an
NRP, taking into account the topology of the molecule (linear, cyclic,
branched, etc.). In the string representation used by the computa-
tional tools (i.e. “Val,Orn,Leu,D-Phe,Pro@1@0,2@1,3@2,4@3”), the
monomers are listed, separated by commas; the @ character sym-
bolizes the links between numbered monomers (explained in more
details in the “structure search” part of the help tab). However, in
most use-cases the string can be automatically generated with the
graphical editor applet provided in the structure search form. Users
only have to draw a peptide (or fragments of a peptide) by picking
the monomers in the list proposed on the left side, and connect-
ing the monomers, once they are placed on the drawing area. Fig. 2
illustrates an example of structure search results obtained for the
linear peptide “Val_Orn_Leu_D-Phe_Pro” using the representation
in NOR format generated by the graphical editor.
Advantages of structure-based search are manifold. First, using
the graph representation of an NRP in Norine structure-based search
tools enables to ﬁnd similar NRPs that can be variants, or identical
compounds from a structure point of view independent of their
names/annotations. Second, we are convinced that the diversity of
the biological activities of NRPs comes from their monomeric com-
position and the diversity of their structures.18 That is the reason
why the structure-based search tools can help predict biological ac-
tivities of an NRP. Indeed, similar NRPs probably share common
properties such as their known activities. Finally, the structure com-
parison tools may be helpful to annotate NRPS coding genes/
clusters within a microorganism genome sequence. Indeed, peptides
with similar monomeric structures may be produced by NRPSs with
close modular organization.
Examples presented below further illustrate the different use
cases.
2.2. Norine database is now open to crowdsourcing
With the development of high throughput technologies dedi-
cated to the screening of secondary metabolites, the number
of published descriptions of new NRPs is increasing exponen-
tially. Considering that researchers are the best experts to annotate
the NRPs they are working on, we have decided to open Norine
to crowdsourcing.10 We have facilitated the process of entering
NRPs into the database by developing an interface for peptide
submission and modiﬁcation by contributors/curators. In order to
use this MyNorine interface, users ﬁrstly register by creating an
account. Standardized forms are provided to submit new peptides
or update records for existing peptide entries. The entered data are
thereafter reviewed by validators of the Norine team. That process
is crucial to ensure that peptides stored in Norine are expert
Fig. 2. Structure search results. Screenshots of the results obtained using the linear pentapeptide “Val_Orn_Leu_D-Phe_Pro” as a pattern (drawn as graph and transformed
in NOR format by the graphical editor) for structural comparison.
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validated as this guarantees the quality of the data. The contribu-
tions will help enrich the Norine database. The contributors will be
mentioned as the authors of the entry.
3. Use cases
3.1. Identiﬁcation of novel CLPs produced by Pseudomonas CMR12a
With the aim of discovering new cyclic lipopeptides (CLPs) with
potential biocontrol activity, a combination of chemical structure
analysis and in silico analysis of the genes encoding NRPSs was
carried out on Pseudomonas CMR12a.19 The strain was shown to
produce two components originally named CLP1 and CLP2 with 18
and 10 amino acid monomers within the peptide backbone, re-
spectively. The structures of both compounds were elucidated and
compared to the structure of all the peptides stored in Norine, using
the “structure search” interface. A peptide named orfamide B was
identiﬁed in the database that matched exactly to the peptide se-
quence of CLP2 (Fig. 3). CLP1 was identiﬁed as being a newmember
of the tolaasin group,20 displaying only one substitution on the
monomer at position 6 (Fig. 3). Thus, the tolaasin group, which com-
prises at least 11 CLPs produced by different Pseudomonas strains
(7 tolaasins, 2 corpeptins and 2 fuscopeptins), was extended with
this new member, named sessilin according to its involvement in
bioﬁlm formation.19 This example demonstrates the relevancy of
structure search tool of the Norine resource to evaluate the novelty
of peptides detected during a screening for active secondary
metabolites.
3.2. Gratisin shares a pattern with the well-known gramicidin S
Gratisin is an undecapeptide with antibiotic activity produced
by Brevibacillus brevis formerly named Bacillus brevis Y-33. Consid-
ering its primary cyclic structure,21 including a D-enantiomer of
phenylalanine, and the presence of the nonproteogenic amino-
acid ornithine, it was assumed to be nonribosomally synthesized.
An entry was created in the Norine database with a “putative” status
because no NRPS associated with gratisin biosynthesis was known.
The structure-based search returned 5 peptides sharing a pattern
constituted of the pentapeptide motif “Val,Orn, Leu, D-Phe, Pro”. All
the 5 peptides display antibiotic activity and are produced by Ba-
cillus strains: four belonging to tyrocidin family (tyrocidins A, B, C
and D) and the ﬁfth one is the decapeptide gramicidin S (Fig. 2), in
which the same pattern is repeated twice due to an iterative mode
of biosynthesis1,22 (Fig. 4). Even if the synthetase has not yet been
identiﬁed in any sequenced Bacillus genome, we can guess that
gratisin is nonribosomally synthesized with an NRPS also using an
iterative mode of biosynthesis because it also contains a repeated
motif. This example shows that the structure comparison of the ﬁnal
peptide may give insights into the biosynthetic pathway and thus
contributes to the prediction of the modular organization of its pro-
ducing NRPS. This can facilitate the identiﬁcation of the genes or
clusters directly involved in the production of suchmetabolites using
genome-mining approaches.
3.3. Cepaciachelin: from putative to curated status
Twenty years ago, the structure of a siderophore produced by
Burkholderia ambifaria strain PHP7 (LMG 11351) was elucidated.23
It is a small compound composed of only 4 monomers: one lysine
is bond to one putrescine and to two residues of di-hydroxy-
benzoic acid (abbreviated Dhb or diOH-Bz). For siderophores a
nonribosomal origin can not be systematically attributed because
some of them, like anguibactin or enterobactin,24 are synthesized
by NRPSs, whereas others, like desferrioxamine, are built up by
other enzymes.25 During a genome-mining analysis, we have iden-
tiﬁed a gene cluster within the genome of B. ambifaria AMMD that
is responsible for the cepaciachelin production (personal commu-
nication). Norine was directly queried with the NRP sequence
predicted by antiSMASH, resulting in a hit against cepaciachelin. As
there is a functional conﬁrmation that cepaciachelin is indeed an
NRP, the status Norine entry now could be updated from “puta-
tive” to “curated” (Norine ID = NOR01254). Cepaciachelin represents
the ﬁfth curated diOH-Bz containing peptide with a siderophore ac-
tivity annotated in the Norine database.
4. Conclusion
Norine (http://bioinfo.liﬂ.fr/NRP) is a freely available and unique
resource dedicated to nonribosomal peptides (NRPs).10 A user-
friendly interface allows easy browsing, annotation, structure
searching and downloading of the NRPs and their monomers. To
discover new natural products, Norine may be the ﬁnal step of a
workﬂow, which is aimed at detecting the potential for new NRP
biosynthesis from genomic data.7 In case where compounds are iden-
tiﬁed as being newNRPs or variants of an existing family, researchers
can now submit them directly to Norine with the easy-to-use
MyNorine interface. The scientiﬁc community will contribute to and
beneﬁt from the enriched resource, improving the screening for NRPs
with biological or medical applications.
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C8:0-OH(3)-dhAbu-Pro-Ser-Leu-Val-Gln-Leu-Val-Val-Gln-Leu-Val-dhAbu-aThr-Ile-Hse-Dab-Lys
C8:0-OH(3)-dhAbu-Pro-Ser-Leu-Val-Ser-Leu-Val-Val-Gln-Leu-Val-dhAbu-aThr-Ile-Hse-Dab-Lys
CLP1/sessilin
Tolaasin
CLP2
Orfamide B C14:0-OH(3)-Leu- Glu-aThr-Val-Leu-Ser-Leu-Leu-Ser-Val
C14:1-OH(3)-Leu- Glu-aThr-Val-Leu-Ser-Leu-Leu-Ser-Val
Fig. 3. Structural comparison of sessilin and CLP2 produced by Pseudomonas CMR12a with tolaasin and orfamide. The monomers have been aligned, the full lines repre-
sent the cyclization within the peptidic part. The variable amino acids in the peptide moiety are in bold and surrounded, small variability within the acyl moiety is highlighted
by a dotted circle.
92 M. Pupin et al./Synthetic and Systems Biotechnology 1 (2016) 89–94
Fig. 4. Structure comparison at the monomeric level. (A) Gratisin, (B) Gramicidin S. Top: monomeric representation as returned by the integrated smiles2monomers tool (s2m). Middle: monomers composing the peptides
identiﬁed by s2m. Bottom: schematic representation highlighting the repetition of a common pentapeptide motif and the differences between both molecules.
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